Abstract
In the global pharmaceutical market, innovation and imitation processes play a key role in companies’ development policies. Through the analysis of the main pharmaceutical companies (originator and generic pharmaceutical companies), this paper aims to identify features that qualify companies themselves, with a particular focus on new product R&D processes.
Keywords
Full Text:
PDFDOI: http://dx.doi.org/10.4468/2015.2.05riboldazzi
References
Refbacks
- There are currently no refbacks.
________________________________________________________________________________________________________
NICCOLO’ CUSANO UNIVERSITY
Via Don Carlo Gnocchi 3, 00166 Rome, Italy
Tel. +39.06.45678350 – FAX +39.06.45678379 - email: symphonya@unicusano.it